Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients

Retina

Volumn 33, Issue 7, 2013, Pages 1435-1440

  Adán, Alfredo ^a   Pelegrín, Laura ^a   Rey, Amanda ^a   Llorenç, Victor ^a   Mesquida, Marina ^a   Molins, Blanca ^b   Ríos, José ^c   Keller, Johannes ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; CYCLOSPORIN; DEXAMETHASONE; INFLIXIMAB; INTERFERON; MYCOPHENOLIC ACID; STEROID; ANTIINFLAMMATORY AGENT; DRUG IMPLANT;

ADULT; AGED; ARTICLE; CENTRAL RETINAL THICKNESS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; HYPOTONY MACULOPATHY; INTRAOCULAR HYPERTENSION; INTRAVITREAL IMPLANT; MALE; MEDICAL RECORD REVIEW; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA CYSTOID EDEMA; UVEA DISEASE; UVEITIC MACULAR EDEMA; VISUAL ACUITY; VITRECTOMY; COMPLICATION; DRUG IMPLANT; INTRAOCULAR PRESSURE; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; MIDDLE AGED; RETROSPECTIVE STUDY; UVEITIS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; UVEITIS; VISUAL ACUITY; VITRECTOMY; YOUNG ADULT;

EID: 84879930015     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31827e247b     Document Type: Article

References (16)

1. Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 1996;80:844-848.
2. Lardenoye CW, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology 2006;113: 1146-1149.
3. Kiryu J, Kita M, Tanabe T, et al. Pars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitis. Ophthalmology 2001;108:1140-1144.
4. Wiechens B, Nölle B, Reichelt JA. Pars-plana vitrectomy in cystoid macular edema associated with intermediate uveitis. Graefes Arch Clin Exp Ophthalmol 2001;239:474-481.
5. Heiligenhaus A, Bornfeld N, Wessing A. Long-term results of pars plana vitrectomy in the management of intermediate uveitis. Curr Opin Ophthalmol 1996;7:77-79.
6. Lowder C, Belfort R, Lightman S, et al Ozurdex HURON Study Group. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 2011;129:545-553.
7. Rothova A. Medical treatment of cystoid macular edema. Ocul Immunol Inflamm 2002;10:239-246.
8. Leder HA, Jabs DA, Galor A, et al. Periocular triamcinolone acetonide injections for cystoid macular edema complicating noninfectious uveitis. Am J Ophthalmol 2011;152:441-448.
9. Antcliff RJ, Spalton DJ, Stanford MR, et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001;108:765-772.
10. Degenring RF, Jonas JB. Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis. Br J Ophthalmol 2003;87:361.
11. Chin HS, Park TS, Moon YS, Oh JH. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and non vitrectomized eyes. Retina 2005;25:556-560.
12. Chang-Lin JE, Burke JA, Peng Q, et al. Pharmacokinetics of a sustained-release dexamethasone intravitreal implant in vitrectomized and nonvitrectomized eyes. Invest Ophthalmol Vis Sci 2011;52:4605-4609.
13. Boyer DS, Faber D, Gupta S, et al Ozurdex CHAMPLAIN Study Group. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 2011;31:915-923.
14. Yeh WS, Haller JA, Lanzetta P, et al. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant. Ophthalmology 2012;119:1190-1198.
15. Bansal R, Bansal P, Kulkarni P, et al. Wandering Ozurdex- implant. J Ophthalmic Inflamm Infect 2012;2:1-5.
16. Williams GA, Haller JA, Kupperman BD, et al; Dexamethasone DDS Phase II Study Group. Dexamethasone posterior segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Am J Ophthalmol 2009;147:1048-1054.